Rahuldeb Sarkar

Rahuldeb Sarkar

Auto-generated profile, based on publicly available information

Rahuldeb Sarkar

Department of Respiratory Medicine and Critical Care, Medway NHS Foundation Trust, Gillingham ME7 5NY, UK; Faculty of Life Sciences and Medicine, King's College London, London, UK

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2013 in Medical Journal Armed Forces India
Verified
Journal Article
Open access
SKSatish Kumar
Satish Kumar
RGR.M. Gupta
R.M. Gupta
SSSourav Sen
Sourav Sen
RSR.S. Sarkar
R.S. Sarkar
JPJ. Philip
J. Philip
SSS.H. Sumathi
S.H. Sumathi
Human parvovirus B19 is an emerging transfusion transmitted infection. Although parvovirus B19 infection is connected with severe complications in some recipients, donor screening is not yet mandatory. To reduce the risk of contamination, plasma-pool screening and exclusion of highly viraemic donations are recommended. In this study the prevalence of parvovirus B19 in healthy blood donors was detected by ELISA. A total of 1633 samples were screened for IgM and IgG antibodies against parvovirus B19 by ELISA. The initial 540 samples were screened for both IgM and IgG class antibodies and remaining 1093 samples were screened for only IgM class antibodies by ELISA. Net prevalence of IgM antibodies to human parvovirus B19 in our study was 7.53% and prevalence of IgG antibodies was 27.96%. Dual positivity (IgG and IgM) was 2.40%. The seroprevalence of human parvovirus B19 among blood donor population in our study is high, and poses an adverse transfusion risk especially in high-risk group of patients who have no detectable antibodies to B19. Studies with large sample size are needed to validate these results.

16 October 2021 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
KMKuruba Manohar
Kuruba Manohar
RGRishikesh Kumar Gupta
Rishikesh Kumar Gupta
PGParth Gupta
Parth Gupta
DSDebasmita Saha
Debasmita Saha
SGSuman Gare
Suman Gare
LGLopamudra Giri
Lopamudra Giri

8 June 2021 in medRxiv
Verified
Preprint
Open access
PDF file
PHPeter W Horby
Peter W Horby
GPGuilherme Pessoa-Amorim
Guilherme Pessoa-Amorim
NSNatalie Staplin
Natalie Staplin
JEJonathan R Emberson
Jonathan R Emberson
MCMark Campbell
Mark Campbell
MLMartin J Landray
Martin J Landray
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its antithrombotic properties. Methods In this randomised, controlled, open-label platform trial, several possible treatments were compared with usual care in patients hospitalised with COVID-19. Eligible and consenting adults were randomly allocated in a 1:1 ratio to either usual standard of care plus 150mg aspirin once daily until discharge or usual standard of care alone using web-based simple (unstratified) randomisation with allocation concealment. The primary outcome was 28-day mortality. The trial is registered with ISRCTN (50189673) and clinicaltrials.gov (NCT04381936). Findings Between 01 November 2020 and 21 March 2021, 7351 patients were randomly allocated to receive aspirin and 7541 patients to receive usual care alone. Overall, 1222 (17%) patients allocated to aspirin and 1299 (17%) patients allocated to usual care died within 28 days (rate ratio 0·96; 95% confidence interval [CI] 0·89-1·04; p=0·35). Consistent results were seen in all pre-specified subgroups of patients. Patients allocated to aspirin had a slightly shorter duration of hospitalisation (median 8 vs. 9 days) and a higher proportion were discharged from hospital alive within 28 days (75% vs. 74%; rate ratio 1·06; 95% CI 1·02-1·10; p=0·0062). Among those not on invasive mechanical ventilation at baseline, there was no significant difference in the proportion meeting the composite endpoint of invasive mechanical ventilation or death (21% vs. 22%; risk ratio 0·96; 95% CI 0·90-1·03; p=0·23). Aspirin use was associated with an absolute reduction in thrombotic events of 0.6% (SE 0.4%) and an absolute increase in major bleeding events of 0.6% (SE 0.2%). Interpretation In patients hospitalised with COVID-19, aspirin was not associated with reductions in 28-day mortality or in the risk of progressing to invasive mechanical ventilation or death but was associated with a small increase in the rate of being discharged alive within 28 days. Funding UK Research and Innovation (Medical Research Council), National Institute of Health Research (Grant ref: MC_PC_19056), and the Wellcome Trust (Grant Ref: 222406/Z/20/Z) through the COVID-19 Therapeutics Accelerator.

1 February 2005 in Global Business Review
Verified
Journal Article
Closed access
RSR. Sarkar
R. Sarkar
RBRajat K. Baisya
Rajat K. Baisya
In India, the domestic airlines industry is going through an interesting phase with three-way competition among Indian Airlines, Jet Airways and Air Sahara and the possibility of emerging competition from budget airlines in the future. This article examines two areas related to the domestic airlines industry: the market dynamics of the industry and some aspects of customer satisfaction. The changing market dynamics over the last few years and its various causal factors are also seen. The initial findings of a research study are highlighted and the relative importance of satisfaction variables and the linkage between customer satisfaction and future usage are examined.

1 April 2008
Verified
Conference Paper
Closed access
XZX. Zhu
X. Zhu
RSR. Sarkar
R. Sarkar
JGJ. Gao
J. Gao
JMJ. S. B. Mitchell
J. S. B. Mitchell
We study the problem of contour tracking with binary sensors, an important problem for monitoring spatial signals and tracking group targets. In particular, we track the boundaries of the blobs of interest and capture the topological changes as the blobs merge or split. Only the nodes on the boundaries of these deformable blobs stay active and the repair cost is proportional to the size of the contour changes. Our algorithm is completely distributed, requires only local information, and yet captures the global topological properties. The algorithm performs a fundamental monitoring function and is a foundation for further information processing of spatial sensor data.

20 January 2021 in medRxiv
Verified
Preprint
Open access
PDF file
RSRahuldeb Sarkar
Rahuldeb Sarkar
CMChristopher Martin
Christopher Martin
HMHeather Mattie
Heather Mattie
Judy Wawira GichoyaJudy Wawira Gichoya
Judy Wawira Gichoya
DSDavid J. Stone
David J. Stone
LCLeo Anthony Celi
Leo Anthony Celi
Background Despite wide utilisation of severity scoring systems for case-mix determination and benchmarking in the intensive care unit, the possibility of scoring bias across ethnicities has not been examined. Recent guidelines on the use of illness severity scores to inform triage decisions for allocation of scarce resources such as mechanical ventilation during the current COVID-19 pandemic warrant examination for possible bias in these models. We investigated the performance of three severity scoring systems (APACHE IVa, OASIS, SOFA) across ethnic groups in two large ICU databases in order to identify possible ethnicity-based bias. Method Data from the eICU Collaborative Research Database and the Medical Information Mart for Intensive Care were analysed for score performance in Asians, African Americans, Hispanics and Whites after appropriate exclusions. Discrimination and calibration were determined for all three scoring systems in all four groups. Findings While measurements of discrimination -area under the receiver operating characteristic curve (AUROC) -were significantly different among the groups, they did not display any discernible systematic patterns of bias. In contrast, measurements of calibration -standardised mortality ratio (SMR) -indicated persistent, and in some cases significant, patterns of difference between Hispanics and African Americans versus Asians and Whites. The differences between African Americans and Whites were consistently statistically significant. While calibrations were imperfect for all groups, the scores consistently demonstrated a pattern of over-predicting mortality for African Americans and Hispanics. Interpretation The systematic differences in calibration across ethnic groups suggest that illness severity scores reflect bias in their predictions of mortality. Funding LAC is funded by the National Institute of Health through NIBIB R01 EB017205. There was no specific funding for this study.